Novartis AG today announced that it has successfully completed its acquisition of Avidity Biosciences, Inc. (“Avidity”). With the completion of the acquisition, Avidity is now an indirect, wholly owned subsidiary of Novartis. “Avidity’s breakthrough science combined with Novartis capabilities will…
GSK announced the completion of its previously announced acquisition of RAPT Therapeutics, a California-based, clinical-stage biopharmaceutical company dedicated to developing novel therapies for patients living with inflammatory and immunologic diseases. The acquisition includes ozureprubart, a long-acting anti-immunoglobulin E (IgE) monoclonal…
AstraZeneca has entered into a definitive agreement to acquire EsoBiotec, a biotechnology company pioneering in vivo cell therapies that has demonstrated promising early clinical activity. The EsoBiotec Engineered NanoBody Lentiviral (ENaBL) platform empowers the immune system to attack cancers and…
Could you share some significant milestones from your career? With over 25 years at the helm as Managing Director of Ami Polymer Pvt. Ltd. (APPL), me and my dynamic team have led the company to international prominence as a key player…
The 54th issue of Pharmaceutical Business Review International presents an exclusive interview with Ruşen Kalender, Chairman of the Board of World Medicine, one of Turkey’s prominent pharmaceutical manufacturers. Mr. Kalender shared insights into the company’s new investments supporting its ongoing…
AbbVie announced that the independent directors of the board have selected Roxanne Austin as lead independent director, effective July 1, 2024. Ms. Austin succeeds Glenn F. Tilton, who has served as lead independent director since 2013. Mr. Tilton will continue to serve…
Eli Lilly and Company announced that Melissa Seymour, MBA will join the company as executive vice president of Global Quality and member of the company’s Executive Committee, effective July 22, 2024. Seymour currently serves as the chief quality officer for…
Metaphore Biotechnologies, a Flagship-founded biotechnology company designing novel therapeutics by combining machine learning and molecular mimicry, today joined Flagship Pioneering in announcing a research collaboration with Novo Nordisk to develop up to two next-generation therapeutics for obesity management. The collaboration is…
Novartis has entered into an agreement to acquire Mariana Oncology, a preclinical-stage biotechnology company based in Watertown, Massachusetts focused on developing novel radioligand therapies (RLTs) to treat cancers with high unmet patient need. 👉 Transaction reinforces company’s strategic focus on developing next-generation treatment options for patients living with cancer.…
Walgreens and Boehringer Ingelheim today announced a strategic collaboration aimed at optimizing recruitment and making clinical trials more accessible, inclusive and equitable. This collaboration will offer people an opportunity to learn about and potentially participate in an important Phase III clinical trial within the familiar and accessible environment of Walgreens…